<?xml version="1.0" encoding="UTF-8"?>
<p>Responses of the 45 enrolled patients are shown in Table 
 <xref rid="cas13719-tbl-0002" ref-type="table">2</xref>. ORR and CR rates after R‐High‐CHOP/CHASER induction therapy were 95.6% (95% CI 84.9‐99.5%) and 82.2% (95% CI 68.0‐92.0%), respectively. ORR and CR rates in all 45 patients after induction and LEED therapy were 77.8% (95% CI 62.9‐88.8%) and 71.1% (95% CI 55.7‐83.6%), respectively.
</p>
